Drug Safety Research Unit (DSRU), Southampton, UK, United Kingdom
Disclosure information not submitted.
5C-01 - Monitoring the Safety of mRNA-1273 COVID-19 Vaccine in the General Population: Results of a Regulator-mandated Post-authorisation Safety Study in Denmark, Norway, Spain, and the United Kingdom (EUPAS44273).
Tuesday, August 26, 20258:30 AM - 8:45 AM ET
5D-02 - Assessing a Signal of Congenital Anomalies Following Dydrogesterone Exposure in Pregnancy: Results From a Disproportionality Analysis (DPA) and Systematic Review
Tuesday, August 26, 20258:45 AM - 9:00 AM ET